Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

BACKGROUND: In SMILE-4 (the Survival of Myocardial Infarction Long-term Evaluation 4 study), zofenopril + acetylsalicylic acid (ASA) was superior to ramipril + ASA in reducing the occurrence of major cardiovascular events in patients with left ventricular dysfunction following acute myocardial infar...

Descripción completa

Detalles Bibliográficos
Autores principales: Borghi, Claudio, Ambrosioni, Ettore, Omboni, Stefano, Cicero, Arrigo FG, Bacchelli, Stefano, Esposti, Daniela Degli, Novo, Salvatore, Vinereanu, Dragos, Ambrosio, Giuseppe, Reggiardo, Giorgio, Zava, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709649/
https://www.ncbi.nlm.nih.gov/pubmed/23882152
http://dx.doi.org/10.2147/CEOR.S43138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709649/
https://www.ncbi.nlm.nih.gov/pubmed/23882152
http://dx.doi.org/10.2147/CEOR.S43138

Ejemplares similares